Newbury Pharmaceuticals: The local specialist - Redeye

Redeye initiates coverage of Newbury Pharmaceuticals, a hybrid pharmaceutical company focusing on providing specialty and branded products on the Scandinavian markets. We identify rapid growth opportunities rooted in an exciting pipeline, bolstered by strong management with extensive sector expertise. We argue that the share offers de-risked exposure to an ever-growing pharmaceutical market and see several potential catalysts ahead.

Länk till analysen i sin helhet: https://www.redeye.se/research/867477/newbury-pharmaceuticals-the-local-specialist?utm_source=finwire&utm_medium=RSS